A detailed history of Trust CO Of Vermont transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Trust CO Of Vermont holds 253 shares of BLUE stock, worth $88. This represents 0.0% of its overall portfolio holdings.

Number of Shares
253
Previous 253 -0.0%
Holding current value
$88
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

BUY
$2.94 - $5.23 $743 - $1,323
253 New
253 $6,000
Q1 2022

Apr 05, 2022

SELL
$4.07 - $10.6 $1,029 - $2,681
-253 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$8.96 - $16.31 $2,266 - $4,126
253 New
253 $6,000
Q3 2021

Oct 22, 2021

SELL
$11.24 - $21.0 $2,843 - $5,313
-253 Closed
0 $0
Q2 2019

Jul 26, 2019

BUY
$75.84 - $105.21 $5,536 - $7,680
73 Added 40.56%
253 $32,000
Q1 2019

May 01, 2019

BUY
$64.44 - $104.11 $451 - $728
7 Added 4.05%
180 $28,000
Q3 2018

Oct 26, 2018

BUY
$88.86 - $117.49 $5,509 - $7,284
62 Added 55.86%
173 $25,000
Q2 2018

Jul 11, 2018

BUY
$99.64 - $127.59 $11,060 - $14,162
111 New
111 $17,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $27M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Trust CO Of Vermont Portfolio

Follow Trust CO Of Vermont and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.